Benefits of Premium Membership

Cells That Draw Immune Cells to Cancerous Tumors Identified

by Chrisy Ngilneii on  February 9, 2018 at 4:59 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Immune cells called Natural Killer (NK) cells accumulate in tumors and release chemicals that attract specialized dendritic cells (cDC1) which are white blood cells known for triggering anti-cancer immune responses - to the tumor, according to recent research at the Francis Crick Institute.
Cells That Draw Immune Cells to Cancerous Tumors Identified
Cells That Draw Immune Cells to Cancerous Tumors Identified

These findings could help develop better immunotherapies for cancer.

Show Full Article


Genes associated with Natural Killer cells and cDC1 correlated with cancer patient survival in a dataset of over 2,500 patients with skin, breast, neck and lung cancers. A similar correlation was seen in an independent group of breast cancer patients, with a particularly positive outcome for women with triple-negative breast cancer, which typically has a poor prognosis.

"Our findings have given us a renewed appreciation of the importance of Natural Killer cells and cDC1 in the immune response against cancer," says Professor Caetano Reis e Sousa, Senior Group Leader at the Crick, who led the study. "It's still early days, but attracting more cDC1 to tumors could be the basis of a new immunotherapy for cancer patients."

The team also showed that prostaglandin E2 (PGE2), a molecule produced by some cancer cells, suppresses Natural Killer cell activity and reduces the responsiveness of cDC1 to the chemical attractants. This suggests that blocking PGE2 with aspirin might help boost the effectiveness of immunotherapies by restoring cDC1 levels in tumors.

"Now that we know a bit better how this key anti-cancer response works, we can look at identifying other ways in which cancers get around it," says Caetano. "This understanding will ultimately help us to develop new immunotherapy approaches to help more patients."

Professor Karen Vousden, Cancer Research UK's chief scientist, said: "This interesting research reveals more about the way the body's immune system interacts with cancer, exposing one way in which cancer can avoid attack.

"Studies like this highlight the complexity of this relationship and may reveal another way in which the immune system can be harnessed to treat cancer. It's vital that work continues to help make immunotherapies more effective and beneficial to more patients."

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive